Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III–IV epithelial ovarian cancer

被引:0
|
作者
Yutaka Iwagoi
Takeshi Motohara
Sangyoon Hwang
Koichi Fujimoto
Tokunori Ikeda
Hidetaka Katabuchi
机构
[1] Kumamoto University,Department of Obstetrics and Gynecology, Faculty of Life Sciences
[2] Fukuoka University Hospital,Department of Clinical Laboratory
[3] Sojo University,Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences
[4] Kumamoto University Hospital,Department of Medical Information Sciences and Administration Planning
关键词
Ovarian cancer; Omental metastasis; Prognosis; Chemoresistance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:995 / 1004
页数:9
相关论文
共 50 条
  • [11] Paclitaxel and carboplatin as outpatient therapy for stage III and IV epithelial ovarian cancer
    Balbi, GC
    Menditto, A
    Calabria, G
    Musone, R
    Di Prisco, L
    Cassese, E
    Balbi, C
    Cardone, A
    PANMINERVA MEDICA, 2001, 43 (04) : 263 - 265
  • [12] Lymphocyte and macrophage infiltration in omental metastases indicates poor prognosis in advance stage epithelial ovarian cancer
    Zhang, Tao
    Liu, Qin
    Zhu, Yingfan
    Huang, Yizhou
    Qin, Jiale
    Wu, Xiaodong
    Zhang, Songfa
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (12)
  • [13] Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
    Mackay, Helen J.
    Brady, Mark F.
    Oza, Amit M.
    Reuss, Alexander
    Pujade-Lauraine, Eric
    Swart, Ann M.
    Siddiqui, Nadeem
    Colombo, Nicoletta
    Bookman, Michael A.
    Pfisterer, Jacobus
    du Bois, Andreas
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (06) : 945 - 952
  • [14] EPITHELIAL OVARIAN CARCINOMAS, STAGE-III AND STAGE-IV - INFLUENCE OF SURGICAL TUMORAL REDUCTION ON THE PROGNOSIS
    LEBOUEDEC, G
    BENAHMED, S
    PLAGNE, R
    DAUPLAT, J
    PRESSE MEDICALE, 1990, 19 (11): : 506 - 510
  • [15] PATIENTS WITH STAGE IV EPITHELIAL OVARIAN CANCER: UNDERSTANDING THE DETERMINANTS OF SURVIVAL
    Dabi, Y.
    Huchon, C.
    Ouldamer, L.
    Bendifallah, S.
    Collinet, P.
    Bricou, A.
    Darai, E.
    Ballester, M.
    Lavoue, V.
    Haddad, B.
    Touboul, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A453 - A454
  • [16] Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival
    Yohann Dabi
    Cyrille Huchon
    Lobna Ouldamer
    Sofiane Bendifallah
    Pierre Collinet
    Alexandre Bricou
    Emile Daraï
    Marcos Ballester
    Vincent Lavoue
    Bassam Haddad
    Cyril Touboul
    Journal of Translational Medicine, 18
  • [17] Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival
    Dabi, Yohann
    Huchon, Cyrille
    Ouldamer, Lobna
    Bendifallah, Sofiane
    Collinet, Pierre
    Bricou, Alexandre
    Darai, Emile
    Ballester, Marcos
    Lavoue, Vincent
    Haddad, Bassam
    Touboul, Cyril
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [18] The role of factor (f) XIII in patients with advanced epithelial ovarian cancer (EOC) FIGO III/IV
    Yazdian, M.
    Ataseven, B.
    Schneider, S.
    Baert, T.
    Bommert, M.
    Traut, A.
    du Bois, A.
    Harter, P.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E212 - E212
  • [19] PREDICTIVE FACTORS OF RECURRENCE IN PATIENTS WITH EARLY STAGE EPITHELIAL OVARIAN CANCER
    Ditto, A.
    Daniele, A.
    Martinelli, F.
    Bogani, G.
    Perotto, S.
    Lorusso, D.
    Chiappa, V.
    Raspagliesi, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 418 - 418
  • [20] Effect of different metastasis patterns on the prognosis of patients with stage III high-grade serous ovarian cancer
    Yang, Hongjuan
    Gao, Dongmei
    Wang, Chang
    Jiao, Jinwen
    Yu, Xinping
    Li, Xiangkun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (08): : 3599 - 3606